ClairS: a deep-learning method for long-read tumor-normal pair somatic small variant calling.
Summary
ClairS is a novel deep-learning method specifically designed for calling somatic small variants in tumor-normal pairs using long-read sequencing data. Unlike most existing tools optimized for short reads, ClairS was trained on synthetic somatic variants and real cancer cell lines. The method demonstrated high accuracy, achieving F1 scores of 96.19% for SNVs and 79.67% for indels after training augmentation. The authors emphasize that improved read phasing enabled by long-read sequencing is key to accurate SNV detection, especially at low variant allele fractions. ClairS is presented as a robust and reliable open-source caller.
Analysis
From a bioinformatics perspective, ClairS represents a significant advancement by offering a deep-learning architecture specifically for somatic variant calling from long-read sequencing data, an area where dedicated tools are still scarce. The method was rigorously benchmarked on the Nanopore Q20+ HCC1395-HCC1395BL dataset, with clear performance metrics (F1 scores) established for SNVs and indels, demonstrating a notable improvement after augmenting training data with real cancer cell lines. ClairS's open-source code ensures its reproducibility and allows the scientific community to adopt and validate it. In a clinical context, such a tool could enhance the accuracy of somatic variant detection, particularly for low variant allele fractions that are challenging with short reads, and potentially optimize variant interpretation workflows for long-read sequencing panels.